AirSculpt Technologies Inc (AIRS)
5.38
-0.21
(-3.76%)
USD |
NASDAQ |
Sep 27, 16:00
5.40
+0.02
(+0.37%)
After-Hours: 20:00
AirSculpt Technologies SG&A Expense (TTM): 100.64M for June 30, 2024
SG&A Expense (TTM) Chart
Historical SG&A Expense (TTM) Data
| Date | Value |
|---|---|
| June 30, 2024 | 100.64M |
| March 31, 2024 | 94.26M |
| December 31, 2023 | 102.38M |
| September 30, 2023 | 104.65M |
| June 30, 2023 | 103.02M |
| March 31, 2023 | 101.13M |
| December 31, 2022 | 101.42M |
| Date | Value |
|---|---|
| September 30, 2022 | 108.38M |
| June 30, 2022 | 96.96M |
| March 31, 2022 | 81.28M |
| December 31, 2021 | 65.78M |
| September 30, 2021 | 38.47M |
| June 30, 2021 | 32.69M |
SG&A Expense Definition
SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.
SG&A Expense (TTM) Range, Past 5 Years
32.69M
Minimum
Jun 2021
108.38M
Maximum
Sep 2022
87.00M
Average
100.64M
Median
Jun 2024
SG&A Expense (TTM) Benchmarks
| CVS Health Corp | -- |
| IQVIA Holdings Inc | 2.075B |
| UNIVEC Inc | -- |
| First Physicians Capital Group Inc | 13.42M |
| SCWorx Corp | 2.720M |